Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex
PLOS ONE · 16.05.2023 · 18 (5) · e0285856
DOI: 10.1371/journal.pone.0285856 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 16.05.2023. Verfasst von Kay A Ramsay und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Ceftazidime, Pseudomonas Infections. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand.
Abstract (Originalsprache)
Pseudomonas aeruginosa causes a wide range of severe infections. Ceftazidime, a cephalosporin, is a key antibiotic for treating infections but a significant proportion of isolates are ceftazidime-resistant. The aim of this research was to identify mutations that contribute to resistance, and to quantify the impacts of individual mutations and mutation combinations. Thirty-five mutants with reduced susceptibility to ceftazidime were evolved from two antibiotic-sensitive P . aeruginosa reference strains PAO1 and PA14. Mutations were identified by whole genome sequencing. The evolved mutants tolerated ceftazidime at concentrations between 4 and 1000 times that of the parental bacteria, with most mutants being ceftazidime resistant (minimum inhibitory concentration [MIC] ≥ 32 mg/L). Many mutants were also resistant to meropenem, a carbapenem antibiotic. Twenty-eight genes were mutated in multiple mutants, with dacB and mpl being the most frequently mutated. Mutations in six key genes were engineered into the genome of strain PAO1 individually and in combinations. A dacB mutation by itself increased the ceftazidime MIC by 16-fold although the mutant bacteria remained ceftazidime sensitive (MIC < 32 mg/L). Mutations in ampC , mexR , nalC or nalD increased the MIC by 2- to 4-fold. The MIC of a dacB mutant was increased when combined with a mutation in ampC , rendering the bacteria resistant, whereas other mutation combinations did not increase the MIC above those of single mutants. To determine the clinical relevance of mutations identified through experimental evolution, 173 ceftazidime-resistant and 166 sensitive clinical isolates were analysed for the presence of sequence variants that likely alter function of resistance-associated genes. dacB and ampC sequence variants occur most frequently in both resistant and sensitive clinical isolates. Our findings quantify the individual and combinatorial effects of mutations in different genes on ceftazidime susceptibility and demonstrate that the genetic basis of ceftazidime resistance is complex and multifactorial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Otago, Dunedin, New Zealand.
- Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
- Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, Queensland, Australia.
- Children's Health Research Centre, Faculty of Medicine, The University of Queensland, South Brisbane, Queensland, Australia.
- School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand.
- Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
ORCID-Profile: Kay A Ramsay, Scott C Bell, Wayne M Patrick
Förderung
- Health Research Council of New Zealand
Zitieren
APA
Ramsay, K. A., Rehman, A., Wardell, S. T., Martin, L. W., Bell, S. C., Patrick, W. M., Winstanley, C., & Lamont, I. L. (2023). Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex. PLOS ONE, 18(5), e0285856. https://doi.org/10.1371/journal.pone.0285856
Vancouver
Ramsay KA, Rehman A, Wardell ST, Martin LW, Bell SC, Patrick WM, et al. Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex. PLOS ONE. 2023;18(5):e0285856. doi:10.1371/journal.pone.0285856
BibTeX
@article{Ramsay2023,
author = {Ramsay, Kay A and Rehman, Attika and Wardell, Samuel T and Martin, Lois W and Bell, Scott C and Patrick, Wayne M and Winstanley, Craig and Lamont, Iain L},
title = {Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {5},
pages = {e0285856},
doi = {10.1371/journal.pone.0285856}
}
EUVIMED